181 related articles for article (PubMed ID: 33885951)
1. Testicular cancer follow-up costs in Germany from 2000 to 2015.
Michaeli T; Michaeli J; Michaeli D
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2249-2258. PubMed ID: 33885951
[TBL] [Abstract][Full Text] [Related]
2. Economy of Standards: European Association of Urology Guideline Changes Influence Treatment Costs in Stage I Testicular Cancer Patients.
John A; Baumgart A; Worst T; Heinzelbecker J
Urol Int; 2018; 100(3):279-287. PubMed ID: 29514158
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer follow-up costs in Germany from 2000 to 2015.
Michaeli T; Michaeli D
J Cancer Surviv; 2022 Feb; 16(1):86-94. PubMed ID: 33646503
[TBL] [Abstract][Full Text] [Related]
4. Socio-economic burden of disease: Survivorship costs for bladder cancer.
Michaeli JC; Boch T; Albers S; Michaeli T; Michaeli DT
J Cancer Policy; 2022 Jun; 32():100326. PubMed ID: 35560269
[TBL] [Abstract][Full Text] [Related]
5. Socio-economic burden of disease: Survivorship costs for renal cell carcinoma.
Michaeli JC; Michaeli DT; Boch T; Albers S; Michaeli T
Eur J Cancer Care (Engl); 2022 May; 31(3):e13569. PubMed ID: 35293070
[TBL] [Abstract][Full Text] [Related]
6. What is the value of routine follow-up in stage I seminoma after paraaortic radiotherapy?: an analysis of the German Testicular Cancer Study Group (GTCSG) in 675 prospectively followed patients.
Clasen J; Schmidberger H; Souchon R; Weissbach L; Hartmann M; Hartmann JT; Hehr T; Bamberg M
Strahlenther Onkol; 2009 Jun; 185(6):349-54. PubMed ID: 19506817
[TBL] [Abstract][Full Text] [Related]
7. Testicular cancer guideline adherence and patterns of care in Germany: A nationwide survey.
Nestler T; Baunacke M; Dräger D; von Landenberg N; Groeben C; Huber J
Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12917. PubMed ID: 30252174
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive systematic review of testicular germ cell tumor surveillance.
Groll RJ; Warde P; Jewett MA
Crit Rev Oncol Hematol; 2007 Dec; 64(3):182-97. PubMed ID: 17644403
[TBL] [Abstract][Full Text] [Related]
9. No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer.
De La Pena H; Sharma A; Glicksman C; Joseph J; Subesinghe M; Traill Z; Verrill C; Sullivan M; Redgwell J; Bataillard E; Pintus E; Dallas N; Gogbashian A; Tuthill M; Protheroe A; Hall M
Eur J Cancer; 2017 Oct; 84():354-359. PubMed ID: 28866371
[TBL] [Abstract][Full Text] [Related]
10. Fifteen-year experience of testicular neoplasm in a regional centre.
Dodds LJ; Murphy D; Neerhut G; Leggatt R
Aust N Z J Surg; 1997 Dec; 67(12):857-9. PubMed ID: 9451341
[TBL] [Abstract][Full Text] [Related]
11. Second malignancies in long-term testicular cancer survivors.
Ondrus D; Ondrusova M; Friedova L
Int Urol Nephrol; 2014 Apr; 46(4):749-56. PubMed ID: 24096370
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
13. Long term outcome and cost in the management of stage I testicular seminoma.
Warde P; Gospodarowicz MK; Panzarella T; Chow E; Murphy T; Catton CN; Sturgeon JF; Moore M; Milosevic M; Jewett MA
Can J Urol; 2000 Apr; 7(2):967-72; discussion 973.. PubMed ID: 11119439
[TBL] [Abstract][Full Text] [Related]
14. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer.
Kamran SC; Seisen T; Markt SC; Preston MA; Trinh QD; Frazier LA; Choueiri TK; Martin NE; Nguyen PL; Beard CJ
Eur Urol; 2018 Feb; 73(2):262-270. PubMed ID: 28687143
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma.
Sharda NN; Kinsella TJ; Ritter MA
J Clin Oncol; 1996 Nov; 14(11):2933-9. PubMed ID: 8918490
[TBL] [Abstract][Full Text] [Related]
16. Testicular self-examination and testicular cancer: a cost-utility analysis.
Aberger M; Wilson B; Holzbeierlein JM; Griebling TL; Nangia AK
Cancer Med; 2014 Dec; 3(6):1629-34. PubMed ID: 25103095
[TBL] [Abstract][Full Text] [Related]
17. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
[TBL] [Abstract][Full Text] [Related]
18. Trends in Age and Histology of Testicular Cancer from 1980-2019: A Single-Center Study.
Yamashita S; Koyama J; Goto T; Fujii S; Yamada S; Kawasaki Y; Kawamorita N; Mitsuzuka K; Arai Y; Ito A
Tohoku J Exp Med; 2020 Nov; 252(3):219-224. PubMed ID: 33148936
[TBL] [Abstract][Full Text] [Related]
19. The increasing burden of testicular seminomas and non-seminomas in adolescents and young adults (AYAs): incidence, treatment, disease-specific survival and mortality trends in the Netherlands between 1989 and 2019.
van der Meer DJ; Karim-Kos HE; Elzevier HW; Dinkelman-Smit M; Kerst JM; Atema V; Lehmann V; Husson O; van der Graaf WTA
ESMO Open; 2024 Feb; 9(2):102231. PubMed ID: 38244349
[TBL] [Abstract][Full Text] [Related]
20. Incidence of testicular tumor subtypes according to the updated WHO classification, North Rhine-Westphalia, Germany, 2008-2013.
Stang A; Rusner C; Trabert B; Oosterhuis JW; McGlynn KA; Heidinger O
Andrology; 2019 Jul; 7(4):402-407. PubMed ID: 30578617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
